Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: Population-based case-control study

Vaccine

Volumn 29, Issue 45, 2011, Pages 7975-7981

  Mahmud, Salaheddin ^a   Hammond, Gregory ^a   Elliott, Lawrence ^a,d   Hilderman, Tim ^a,d   Kurbis, Carol ^b   Caetano, Patricia ^a,d   Van Caeseele, Paul ^a,c   Kettner, Joel ^a,d   Dawood, Magdy ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

^c CADHAM PROVINCIAL LABORATORY   (Canada)

^d Manitoba Health   (Canada)

Author keywords

Epidemiology; Pandemic influenza A H1N1; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNIZATION; INFANT; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA B; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MANITOBA; MASS VACCINATION; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053647226     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.068     Document Type: Article

References (31)

1. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine-preliminary report. N Engl J Med 2009, 361(September):2405-2413.
2. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine-preliminary report. N Engl J Med 2009, 361(September):2424-2435.
3. PHAC Guidance document on the use of pandemic influenza A (H1N1) 2009 inactivated monovalent vaccine 2009, Available from: http://www.phac-aspc.gc.ca/alert-alerte/h1n1/vacc/monovacc/immuno-eng.php [cited 9.12.09].
4. Khazeni N., Hutton D.W., Garber A.M., Hupert N., Owens D.K. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med October 2009.
5. Zarychanski R., Stuart T.L., Kumar A., Doucette S., Elliott L., Kettner J., et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010, 182(February (3)):257-264.
6. Thompson LH, Mahmud SM, Keynan Y, Slater J, Dawood M, Fowke K, et al. Serological survey of the novel influenza A H1N1 in inner-city Winnipeg, Manitoba, 2009. Can J Infect Dis Med Micro; in press.
7. Singh H., Mahmud S.M., Turner D., Xue L., Demers A.A., Bernstein C.N. Long-term use of statins and risk of colorectal cancer: a population-based study. Am J Gastroenterol 2009, 104(December (12)):3015-3023.
8. LeBlanc J., Li Y., Bastien N., Forward K., Davidson R., Hatchette T. Switching gears for an influenza pandemic: validation of a duplex reverse transcriptase PCR assay for simultaneous detection and confirmatory identification of pandemic (H1N1) 2009 influenza virus. J Clin Microbiol 2009, 47(12):3805.
9. Roberts J., Poffenroth L., Roos L., Bebchuk J., Carter A. Monitoring childhood immunizations: a Canadian approach. Am J Public Health 1994, 84(10):1666.
10. Martens P.J., Frohlich N., Carriere K.C., Derksen S., Brownell M. Embedding child health within a framework of regional health: population health status and sociodemographic indicators. Can J Public Health 2002, 93(Suppl. 2):S15-S20.
11. Bridges C.B., Katz J.M., Levandowski R.A., Cox N.J. Influenza vaccine (inactivated). Vaccines 2008, 259-290. Elsevier. S. Plotkin, W. Orenstein, P. Offit (Eds.).
12. Clayton D., Hills M. Statistical models in epidemiology 1993, Oxford University Press, Oxford/New York.
13. Dupont W.D. Power calculations for matched case-control studies. Biometrics 1988, 44(4):1157-1168.
14. Simpson C.R., Ritchie L.D., Robertson C., Sheikh A., McMenamin J. Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 2010, 14(July (34)):313-346.
15. Puig-Barberà J., Arnedo-Pena A., Pardo-Serrano F., Tirado-Balaguer M.D., Pérez-Vilar S., Silvestre-Silvestre E., et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28(47):7460-7467.
16. Wu J., Xu F., Lu L., Lu M., Miao L., Gao T., et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010, 363(25):2416-2423.
17. Valenciano M., Kissling E., Cohen J.-M., Oroszi B., Barret A.-S., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8(1):e1000388.
18. Skowronski D.M., Janjua N.Z., De Serres G., Hottes T.S., Dickinson J.A., Crowcroft N., et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ January 2011, 342.
19. Van Buynder P.G., Dhaliwal J.K., Van Buynder J.L., Couturier C., Minville-LeBlanc M., Garceau R., et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses 2010, 4(4):171-178.
20. Demicheli V., Jefferson T., Rivetti D., Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000, 18(11-12):957-1030.
21. Rivetti D., Jefferson T., Thomas R., Rudin M., Rivetti A., Di Pietrantonj C., et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews (Online) 2006, 3.
22. Skowronski D., De Serres G., Crowcroft N., Janjua N., Boulianne N., Hottes T., et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 Illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7(4):e1000258.
23. Viboud C., Simonsen L. Does seasonal influenza vaccination increase the risk of Illness with the 2009 A/H1N1 pandemic virus?. PLoS Med 2010, 7(4):e1000259.
24. Psaty B.M., Koepsell T.D., Lin D., Weiss N.S., Siscovick D.S., Rosendaal F.R., et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999, 47(6):749-754.
25. Nolan T., McVernon J., Skeljo M., Richmond P., Wadia U., Lambert S., et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA December 2009, 1911.
26. Savitz D.A. Interpreting epidemiologic evidence: strategies for study design and analysis 2003, Oxford University Press, Oxford/New York.
27. Young T., Roos L., Gelskey D. Estimating the burden of disease: comparing administrative data and self-reports. Med Care 1997, 35(9):932-947.
28. Roos L., Mustard C., Nicol J., McLerran D., Malenka D., Young T., et al. Registries and administrative data: organization and accuracy. Med Care 1993, 31(3):201-212.
29. Roberts J., Roos L., Poffenroth L., Hassard T., Bebchuk J., Carter A., et al. Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study. J Clin Epidemiol 1996, 49(1):51.
30. Fleming D.M., Andrews N.J., Ellis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010, 64(December (12)):1062-1067.
31. Mahmud S.M., Becker M., Keynan Y., Elliott L., Thompson L.H., Fowke K., et al. Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic. CMAJ 2010, 182(14):1522-1524.